Millions of Americans are affected by viral hepatitis, and too many do not know they are infected.
On World Hepatitis Day, we call attention to this silent epidemic, and we rededicate ourselves to the fight against viral hepatitis.
WHITEHOUSE: Presidential Proclamation -- World Hepatitis Day, 2012
The aim is to ensure that people who are at risk from, or living with, viral hepatitis get the help they need.
As a leading cause of liver cancer and related complications, viral hepatitis presents a major public health challenge at home and abroad.
Worldwide, one in twelve people is living with viral hepatitis -- a disease that threatens the health of millions of Americans and people across the globe.
WHITEHOUSE: Presidential Proclamation -- World Hepatitis Day, 2012
Hepatitis A and B can be prevented with vaccines, which are recommended for all children -- and for adults who are at high risk of contracting viral hepatitis.
WHITEHOUSE: Presidential Proclamation -- World Hepatitis Day, 2012
About half of all liver disease is alcohol related, a third is caused by viral hepatitis and the remainder due to immune system dysfunction, metabolic disorders and inherited diseases.
Though all types of viral hepatitis are associated with serious health issues, hepatitis B and C can become chronic infections that often lead to liver cirrhosis or liver cancer.
WHITEHOUSE: Presidential Proclamation -- World Hepatitis Day, 2012
Broader dissemination and use of these tools, especially by organizations working with AAPI communities at risk, will have a positive impact on our efforts to reduce viral Hepatitis disparities in the AAPI population.
My Administration remains committed to addressing viral hepatitis.
WHITEHOUSE: Presidential Proclamation -- World Hepatitis Day, 2012
On World Hepatitis Day, let us raise awareness of the global health threat of viral hepatitis, renew our support for those living with the disease, and recommit to a future free of this tragic illness.
WHITEHOUSE: Presidential Proclamation -- World Hepatitis Day, 2012
Tragically, complications resulting from viral hepatitis claim thousands of American lives every year -- a burden borne disproportionately by African American, Hispanic, and Asian American and Pacific Islander (AAPI) communities, and by persons born between 1945 and 1965.
WHITEHOUSE: Presidential Proclamation -- World Hepatitis Day, 2012
The United Nations Relief and Works Agency (UNRWA), which looks after Palestinian refugees across the Middle East, says that the rate of infectious diseases, including diarrhoea and viral hepatitis, which result from bad water and sanitation, has risen.
Liver disease, the fifth biggest cause of death in England and Wales behind heart disease, cancer, stroke and respiratory disease, comes in more than 100 forms but is most commonly associated with alcohol abuse, obesity and viral hepatitis.
BBC: Liver damage is 'silent killer' cirrhosis patient warns
After a 2010 study by the Institute of Medicine of the National Academy of Sciences found serious shortcomings in resources and concluded that our approach to viral hepatitis needed a serious overhaul, Assistant Secretary for Health Dr. Howard Koh convened a working group to address the issues identified by the IOM report and its 22 specific recommendations.
The drugs aim either to boost immune response or to attack and inactivate the viral enzymes that hepatitis C uses to replicate, in much the same way that AIDS drugs attack that virus.
Some doctors had reported positive results using ribavirin, an anti-viral medicine used mostly against hepatitis C, as a treatment for SARS patients who had been worst-hit by the disease in Hong Kong and elsewhere.
The company has tried to create new enthusiasm with with efforts to expand into hepatitis C, the viral liver disease that is looking like the next big drug market, and into other areas such as heart disease, cystic fibrosis, and pulmonary arterial hypertension.
FORBES: Gilead Tries To Revive Itself With $11 Billion Purchase Of Pharmasset
Wall Street is bracing for one of the biggest new drug categories in a decade: the launch of a series of antiviral medicines that could dramatically improve the cure rate for hepatitis C, a viral disease that slowly attacks the liver and is often fatal.
Given its safety profile and how easy it is to make, it could quickly be tested as a potential new treatment for viral diseases ranging from dengue and yellow fever to hepatitis, say the US investigators from Georgetown University Medical Center in Washington.
BBC: Dogfish shark chemical squalamine 'stops human viruses'
Overall, the main benefit of this new class of hepatitis C treatments is the improvement in sustained viral load or SVR, according to the docs surveyed.
FORBES: The Hepatitis C Wars: What Docs Say About The Newest Meds
In justifying his strong buy rating on the company, Carl Byrns at Dain Rauscher Wessels points to an anti-viral drug: Peg-intron plus ribavirin combination therapy for Hepatitis C.
But antivirus drugs, aimed at viral, rather than bacterial, invaders--HIV, herpes, hepatitis, flu, the common cold--have been harder to come by because viruses are harder to outwit and tame.
Hepatitis -- the most common types being hepatitis A, B and C -- refers to inflammation or viral infections of one's liver.
应用推荐